Access to antiretroviral therapy in HIV-infected children aged 0–19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004–2015: A prospective cohort study
Open Access
- 4 May 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 15 (5) , e1002565
Abstract
Access to antiretroviral therapy (ART) is a global priority. However, the attrition across the continuum of care for HIV-infected children between their HIV diagnosis and ART initiation is not well known. We analyzed the time from enrollment into HIV care to ART initiation in HIV-infected children within the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium. We included 135,479 HIV-1-infected children, aged 0–19 years and ART-naïve at enrollment, between 1 January 2004 and 31 December 2015, in IeDEA cohorts from Central Africa (3 countries; n = 4,948), East Africa (3 countries; n = 22,827), West Africa (7 countries; n = 7,372), Southern Africa (6 countries; n = 93,799), Asia-Pacific (6 countries; n = 4,045), and Latin America (7 countries; n = 2,488). Follow-up in these cohorts is typically every 3–6 months. We described time to ART initiation and missed opportunities (death or loss to follow-up [LTFU]: last clinical visit >6 months) since baseline (the date of HIV diagnosis or, if unavailable, date of enrollment). Cumulative incidence functions (CIFs) for and determinants of ART initiation were computed, with death and LTFU as competing risks. Among the 135,479 children included, 99,404 (73.4%) initiated ART, 1.9% died, 1.4% were transferred out, and 20.4% were lost to follow-up before ART initiation. The 24-month CIF for ART initiation was 68.2% (95% CI: 67.9%–68.4%); it was lower in sub-Saharan Africa—ranging from 49.8% (95% CI: 48.4%–51.2%) in Central Africa to 72.5% (95% CI: 71.5%–73.5%) in West Africa—compared to Latin America (71.0%, 95% CI: 69.1%–72.7%) and the Asia-Pacific (78.3%, 95% CI: 76.9%–79.6%). Adolescents aged 15–19 years and infants p < 0.01); those aged p < 0.01); those who became eligible during follow-up (versus eligible at enrollment, p < 0.01); and those receiving care in low-income or lower-middle-income countries (p < 0.01). The main limitations of our study include left truncation and survivor bias, caused by deaths of children prior to enrollment, and use of enrollment date as a proxy for missing data on date of HIV diagnosis, which could have led to underestimation of the time between HIV diagnosis and ART initiation. In this study, 68% of HIV-infected children initiated ART by 24 months. However, there was a substantial risk of LTFU before ART initiation, which may also represent undocumented mortality. In 2015, many obstacles to ART initiation remained, with substantial inequities. More effective and targeted interventions to improve access are needed to reach the target of treating 90% of HIV-infected children with ART.Keywords
Funding Information
- National Institutes of Health (U01AI069907)
- National Institutes of Health (U01AI069923)
- National Institute of Allergy and Infectious Diseases (U01AI096299)
- National Institutes of Health (U01AI069911)
- National Institutes of Health (U01AI069924)
- National Institutes of Health (U01AI069919)
This publication has 37 references indexed in Scilit:
- Universal HIV Screening at Postnatal Points of Care: Which Public Health Approach for Early Infant Diagnosis in Côte d'Ivoire?PLOS ONE, 2013
- Integrated maternal and child health services in Mozambique: structural health system limitations overshadow its effect on follow-up of HIV-exposed infantsBMC Health Services Research, 2013
- Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method StudyAIDS Research and Treatment, 2012
- Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic ReviewPLOS Medicine, 2011
- Community-based intervention to increase HIV testing and case detection in people aged 16–32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised studyThe Lancet Infectious Diseases, 2011
- Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventionsBMC Medicine, 2011
- Dynamics and Constraints of Early Infant Diagnosis of HIV Infection in Rural KenyaAIDS and Behavior, 2011
- Lessons learned from family‐centred models of treatment for children living with HIV: current approaches and future directionsJournal of the International AIDS Society, 2010
- Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysisBMC Infectious Diseases, 2009
- Early Antiretroviral Therapy and Mortality among HIV-Infected InfantsNew England Journal of Medicine, 2008